CARMAX INC
For the period ended Nov 30, 2025. Filed Dec 23, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 30, 2025 · Filed Dec 23, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
In connection with information set forth in this Form 10-Q, the factors discussed under “Risk Factors” in our Form 10-K for fiscal year ended February 28, 2025, should be considered. These risks could materially and adversely affect our business, financial condition, and results of operations. There have been no material changes to the factors discussed in our Form 10‑K other than the updated information related to succession planning for our CEO and executive management included below.
Our future success depends in substantial part on our ability to attract, recruit, hire, motivate, develop, and retain talented personnel possessing the qualifications, experiences, capabilities and skills we need for all areas of our organization, including our CEO and members of our senior leadership team. Succession planning to ensure effective transfer of knowledge and a seamless transition when key personnel depart is also important to our long-term success. In November 2025, we announced that on December 1, 2025, Bill Nash was stepping down from his position as CEO and that David McCreight would serve as our Interim President and CEO. Our business could be adversely affected if we fail to successfully execute our succession plan or if our succession plan is not well-received by our employees, investors and other stakeholders. In addition, our ability to execute our business strategies and retain key executives may be adversely affected by the transition and this could have a material adverse effect on our business, sales and results of operations.
In April 2022, the board authorized the repurchase of up to $2 billion of our common stock with no expiration date. Purchases may be made in open market transactions, including through Rule 10b5-1 plans, or privately negotiated transactions at management’s discretion and the timing and amount of repurchases are determined based on stock price, market conditions, legal requirements and other factors. Shares repurchased are deemed authorized but unissued shares of common stock.
The following table provides information relating to the company’s repurchase of common stock for the third quarter of fiscal 2026. The table does not include transactions related to employee equity awards or exercise of employee stock options.
| Approximate | |||||
|---|---|---|---|---|---|
| Dollar Value | |||||
| Total Number · of Shares that | |||||
| Total Number · Average · of Shares Purchased · May Yet Be | |||||
| of Shares · Price Paid · as Part of Publicly · Purchased Under | |||||
| Period · Purchased · per Share · Announced Program · the Program | |||||
| September 1 - 30, 2025 | 1,233,235 | $54.97 | 1,233,235 | $1,489,266,226 | |
| October 1 - 31, 2025 | 1,610,000 | $44.18 | 1,610,000 | $1,418,132,092 | |
| November 1 - 30, 2025 | 1,770,000 | $35.42 | 1,770,000 | $1,355,433,756 | |
| Total | 4,613,235 | 4,613,235 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.